Austin, TX, 05/15/2019. Yesterday, Haima was selected to participate in the MassChallenge Texas in Austin 2019 accelerator program. Haima was one of over 650 other startups to apply for the accelerator located in Austin, Texas.
“I am really excited to tap into the established and renowned MassChallenge Texas and Boston networks to help grow Haima Therapeutics. The next 6 months are going to be very exciting for Haima.” Dr. Michael Bruckman, COO of Haima Therapeutics.
Haima will participate in the MassChallenge Texas in Austin 2019 accelerator program, where it will receive access to MassChallenge's global network, world-class mentoring from industry experts, tailored programming, free co-working space, and unrivalled access to corporate partners. The accelerator culminates on October 2019 at the MassChallenge Texas in Austin Awards Ceremony, where selected startups will pitch for the opportunity to win a portion up to $500K in no-equity cash awards.
About Haima Therapeutics:
Haima Therapeutics is a pre-clinical stage biotechnology company focused on developing bio-inspired therapies for the treatment of bleeding and other blood-related ailments. We have developed a novel, nanoparticle-based synthetic hemostatic technology, called SynthoPlateTM, that can staunch hemorrhagic bleeding by binding to the site of injury and amplifying your body’s natural clotting mechanisms. Learn more at www.haimatherapeutics.com and follow us on twitter @HaimaThr. For more information, please contact Michael Bruckman at email@example.com
MassChallenge is a global network of zero-equity startup accelerators. Headquartered in the United States with locations in Boston, Israel, Mexico, Rhode Island, Switzerland, and Texas, MassChallenge is committed to strengthening the global innovation ecosystem by supporting high-potential startups across all industries, from anywhere in the world. To date, 1,900 MassChallenge alumni have raised more than $4 billion in funding, generated more than $2 billion in revenue, and created over 120,000 total jobs. Learn more about MassChallenge at masschallenge.org.